This week, the BBC reported a story about using gene therapy to treat a rare disorder called choroideremia. The therapy involves injecting working copy of the gene into the back of the eyes to help cells regenerate and the researchers found that not only does the treatment halt the disease, it revives some of the dying cells and improves the patient’s vision, in some cases markedly.

The College’s Clinical Adviser, Dr Susan Blakeney commented on the news:

“It’s very exciting to see the development of a potential new treatment option for choroideremia, particularly since those diagnosed with the inherited disorder have had no treatment options in the past. As with any clinical trial, we look forward to hearing the full outcome, and to see if there are ways in which this concept be applied for the treatment of other eye conditions, such as AMD.”